Prioritizing disease candidate proteins in cardiomyopathy-specific protein-protein interaction networks based on

Wan Li1, Lina Chen, Weiming He

  • 1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang Province, China.

Plos One
|August 14, 2013
PubMed

Insights

This study introduces a bioinformatics method to identify proteins linked to inherited cardiomyopathies. This approach prioritizes candidate proteins, offering a cost-effective way to understand heart muscle disease mechanisms.

Area of Science:

  • Cardiology
  • Genetics
  • Bioinformatics

Background:

  • Cardiomyopathies are inherited heart muscle diseases.
  • Identifying disease-related proteins is crucial for understanding disease mechanisms.
  • Experimental protein identification is costly and time-consuming.

Purpose of the Study:

  • To develop a bioinformatics approach for prioritizing candidate proteins involved in human cardiomyopathies.
  • To leverage protein-protein interaction networks and "guilt by association" analysis.
  • To identify novel disease-related proteins for a comprehensive understanding of cardiomyopathy mechanisms.

Main Methods:

  • Constructed weighted human cardiomyopathy-specific protein-protein interaction networks using known disease proteins.
  • Applied "guilt by association" analysis to rank candidate proteins within the networks.
  • Validated the approach through cross-validation and comparison with other methods.

Main Results:

  • Identified candidate proteins with high scores that share disease-related pathways with known cardiomyopathy proteins.
  • Top-ranked candidate proteins showed relevance to specific cardiomyopathy subtypes.
  • The method successfully prioritized potential novel disease-related proteins.

Conclusions:

  • The developed bioinformatics approach is effective for identifying potential novel disease proteins in cardiomyopathies.
  • This method offers a cost-competitive alternative to experimental identification.
  • The findings provide insights into cardiomyopathy-related mechanisms in a comprehensive and integrated manner.

Related Concept Videos

Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...